Pictet Asset Management (Switzerland)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$46.3M	Buy	373,392 +135,445	+57%	+$18.2M	0.05%	301
2023 Q1	$34.8M	Buy	237,947 +139,807	+142%	+$20.7M	0.04%	353
2022 Q4	$15.6M	Buy	98,140 +17,822	+22%	+$2.61M	0.02%	502
2022 Q3	$10.7M	Sell	80,318 -11,466	-12%	-$1.74M	0.02%	564
2022 Q2	$14.3M	Sell	91,784 -36,765	-29%	-$5.66M	0.02%	523
2022 Q1	$20M	Sell	128,549 -1,918	-1%	-$278K	0.02%	497
2021 Q4	$16.6M	Sell	130,467 -5,061	-4%	-$665K	0.02%	562
2021 Q3	$17.6M	Buy	+135,528	New	+$20.5M	0.02%	542

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s JAZZ Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Jazz Pharmaceuticals (JAZZ) stake by 57% in Q2 2023, buying an estimated $18.2M and bringing the position to 373,392 shares worth $46.3M. The position accounts for 0.05% of the portfolio, ranked #301.

Pictet Asset Management (Switzerland) first reported a position in JAZZ in Q3 2021 and has held it in 8 quarters since. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

Pictet Asset Management (Switzerland) held 373,392 shares of Jazz Pharmaceuticals worth $46.3M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 135,445 Jazz Pharmaceuticals shares in Q2 2023, an estimated $18.2M.
Jazz Pharmaceuticals made up 0.05% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #301 holding.
Pictet Asset Management (Switzerland) first reported a position in Jazz Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.